Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells

Human Gene Therapy

Volumn 20, Issue 8, 2009, Pages 861-870

  Thomas, Darby L ^a   Wang, Lijun ^a   Niamke, Justine ^a,b   Liu, Jilin ^a   Kang, Wen ^a   Scotti, Marina M ^a   Ye, Guo Jie ^a   Veres, Gabor ^a   Knop, David R ^a  

^a APPLIED GENETIC TECHNOLOGIES CORPORATION   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CELL STRAIN BHK; CELL STRAIN HEK293; GENE THERAPY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; SEROTYPE; SUSPENSION CELL CULTURE; TRANSGENE; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALS; BIOREACTORS; BUFFERS; CELL COUNT; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY; DEPENDOVIRUS; HERPESVIRUS 1, HUMAN; HUMANS; SUPERINFECTION; TIME FACTORS; TRANSGENES;

ADENO-ASSOCIATED VIRUS; CRICETINAE; HUMAN HERPESVIRUS 1; MAMMALIA;

EID: 68949198072     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.004     Document Type: Article

References (39)

1. Alazard-Dany, N., Nicolas, A., Ploquin, A., Strasser, R., Greco, A., Epstein, A.L., Fraefel, C., and Salvetti, A. (2009). Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. PLoS Pathog. 5, e1000340.
2. Albu, E., and Holmes, K.V. (1973). Isolation and preliminary characterization of the RNA-containing R-type, virus-like particle of BHK-21 cells. J. Virol. 12, 1164-1172.
3. Aucoin, M.G., Perrier, M., and Kamen, A.A. (2008). Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol. Adv. 26, 73-88.
4. Bergmann, D.G., and Wolff, D.A. (1981). Production of R-type virus-like particles in hamster cells. Intervirology 16, 61-70.
5. Bloch, J., Bachoud-Levi, A.C., Deglon, N., Lefaucheur, J.P., Winkel, L., Palfi, S., Nguyen, J.P., Bourdet, C., Gaura, V., Remy, P., Brugieres, P., Boisse, M.F., Baudic, S., Cesaro, P., Hantraye, P., Aebischer, P., and Peschanski, M. (2004). Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study. Hum. Gene Ther. 15, 968-975.
6. Boedeker, B.G. (2001). Production processes of licensed recombinant factor VIII preparations. Semin. Thromb. Hemost. 27, 385-394.
7. Booth, M.J., Mistry, A., Li, X., Thrasher, A., and Coffin, R.S. (2004). Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids. Gene Ther. 11, 829-837.
8. Buller, R.M., Janik, J.E., Sebring, E.D., and Rose, J.A. (1981). Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J. Virol. 40, 241-247.
9. Buning, H., Perabo, L., Coutelle, O., Quadt-Humme, S., and Hallek, M. (2008). Recent developments in adeno-associated virus vector technology. J. Gene Med. 10, 717-733.
10. Cecchini, S., Negrete, A., and Kotin, R.M. (2008). Toward exascale production of recombinant adeno-associated virus for gene transfer applications. Gene Ther. 15, 823-830.
11. Christie, A., and Butler, M. (1999). The adaptation of BHK cells to a non-ammoniagenic glutamate-based culture medium. Biotechnol. Bioeng. 64, 298-309.
12. Clark, K.R., Voulgaropoulou, F., Fraley, D.M., and Johnson, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6, 1329-1341.
13. Clark, K.R., Voulgaropoulou, F., and Johnson, P.R. (1996). A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther. 3, 1124-1132.
14. Conway, J.E., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1997). Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. J. Virol. 71, 8780-8789.
15. Conway, J.E., Rhys, C.M., Zolotukhin, I., Zolotukhin, S., Muzyczka, N., Hayward, G.S., and Byrne, B.J. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther. 6, 986-993.
16. Pasquale, G., Davidson, B.L., Stein, C.S., Martins, I., Scudiero, D., Monks, A., and Chiorini, J.A. (2003). Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9, 1306-1312.
17. Durocher, Y., Pham, P.L., St-Laurent, G., Jacob, D., Cass, B., Chahal, P., Lau, C.J., Nalbantoglu, J., and Kamen, A. (2007). Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells. J. Virol. Methods 144, 32-40.
18. Farson, D., Harding, T.C., Tao, L., Liu, J., Powell, S., Vimal, V., Yendluri, S., Koprivnikar, K., Ho, K., Twitty, C., Husak, P., Lin, A., Snyder, R.O., and Donahue, B.A. (2004). Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors. J. Gene Med. 6, 1369-1381.
19. Feng, L., Guo, M., Zhang, S., Chu, J., and Zhuang, Y. (2007). Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-β-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells. Biotechnol. Appl. Biochem. 46, 127-135.
20. Feudner, E., De Alwis, M., Thrasher, A.J., Ali, R.R., and Fauser, S. (2001). Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system. J. Virol. Methods 96, 97-105.
21. Hermonat, P.L., andMuzyczka, N. (1984).Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 81, 6466-6470.
22. Hildinger, M., Baldi, L., Stettler, M., and Wurm, F.M. (2007). High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells. Biotechnol. Lett. 29, 1713-1721.
23. Kang, W., Wang, L., Harrell, H., Liu, J., Thomas, D.L., Mayfield, T.L., Scotti, M.M., Ye, G.J., Veres, G., and Knop, D.R. (2009). An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes. Gene Ther. 16, 229-239.
24. Knop, D.R., and Harrell, H. (2007). Bioreactor production of recombinant herpes simplex virus vectors. Biotechnol. Prog. 23, 715-721.
25. Kohlbrenner, E., Aslanidi, G., Nash, K., Shklyaev, S., Campbell-Thompson, M., Byrne, B.J., Snyder, R.O., Muzyczka, N., Warrington, K.H., Jr., and Zolotukhin, S. (2005). Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12, 1217-1225.
26. Mena, J.A., Ramirez, O.T., and Palomares, L.A. (2007). Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles. BMC Biotechnol. 7, 39.
27. Mistry, A.R., De Alwis, M., Feudner, E., Ali, R.R., and Thrasher, A.J. (2002). High-titer stocks of adeno-associated virus from replicating amplicons and herpes vectors. Methods Mol. Med. 69, 445-460.
28. Muzyczka, N., and Berns, K.I. (2001). Parvoviridae: The viruses and their replication. In Fields Virology. D.M. Knipe and P.M. Howley, eds. (Lippincott, Williams & Wilkins, New York) pp. 2327-2360.
29. Negrete, A., Yang, L.C., Mendez, A.F., Levy, J.R., and Kotin, R.M. (2007). Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system. J. Gene Med. 9, 938-948.
30. Park, J.Y., Lim, B.P., Lee, K., Kim, Y.G., and Jo, E.C. (2006). Scalable production of adeno-associated virus type 2 vectors via suspension transfection. Biotechnol. Bioeng. 94, 416-430.
31. Rice, S.A., and Knipe, D.M. (1990). Genetic evidence for two distinct transactivation functions of the herpes simplex virus a protein ICP27. J. Virol. 64, 1704-1715.
32. Salvetti, A., Oreve, S., Chadeuf, G., Favre, D., Cherel, Y., Champion-Arnaud, P., David-Ameline, J., and Moullier, P. (1998). Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9, 695-706.
33. Toublanc, E., Benraiss, A., Bonnin, D., Blouin, V., Brument, N., Cartier, N., Epstein, A.L., Moullier, P., and Salvetti, A. (2004). Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines. J. Gene Med. 6, 555-564.
34. Tratschin, J.D., West, M.H., Sandbank, T., and Carter, B.J. (1984). A human parvovirus, adeno-associated virus, as a eucaryotic vector: Transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol. Cell. Biol. 4, 2072-2081.
35. Urabe, M., Ding, C., and Kotin, R.M. (2002). Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935-1943.
36. Weindler, F.W., and Heilbronn, R. (1991). A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J. Virol. 65, 2476-2483.
37. Wustner, J.T., Arnold, S., Lock, M., Richardson, J.C., Himes, V.B., Kurtzman, G., and Peluso, R.W. (2002). Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap. Mol. Ther. 6, 510-518.
38. Ye, G.-J., Drogemuller, C., Thomas, D.L., Scotti, M.M., Kang, W., Knop, D.R., Boye, S., Pechan, P., Peterson, J., Hauswirth, W., Scaria, A., and Wadsworth, S. (2006). A novel herpes simplex virus helper based production of adeno-associated virus vectors for treatment of retinal angiogenesis. Mol. Ther. 13, S194.
39. Zhang, X., De Alwis, M., Hart, S.L., Fitzke, F.W., Inglis, S.C., Boursnell, M.E., Levinsky, R.J., Kinnon, C., Ali, R.R., and Thrasher, A.J. (1999). High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Hum. Gene Ther. 10, 2527-2537.